Latest filing published 19 Jan 2021 for Inhibitor Therapeutics, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mayne Pharma Ventures Pty Ltd: trading record in brief
This profile gathers the share dealings of Mayne Pharma Ventures Pty Ltd in Inhibitor Therapeutics, Inc. Over a trading history stretching from 4 November 2016 to 15 January 2021, the count stands at 10 filings.
No open-market sale appears; the market trades are 1 purchase. The amount is not disclosed for 1 filing. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 5 share grants.
The newest entry dates from 19 January 2021: a transaction, in Inhibitor Therapeutics, Inc. The most recent open-market purchase was published on 12 February 2018, 3,191 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Mayne Pharma Ventures Pty Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,240,488 shares0Common StockSEC:0001104659-21-005226:0
- 3,189,688 shares0Common StockSEC:0001104659-20-084975:0
- 362,121 shares0Common StockSEC:0001144204-19-002698:0
- 184,798 shares0Common StockSEC:0001144204-18-065264:0
- 600,000 sharesCommon StockSEC:0001144204-18-007440:0Canonical exit: 19 Mar 2018 (T+90)
- 4,750,569 sharesCommon StockSEC:0001144204-16-134828:0
- 333 sharesCommon StockSEC:0001144204-16-134828:1
- 4,860,000 sharesCommon StockSEC:0001144204-16-134828:2
- 5,500,000 sharesCommon StockSEC:0001144204-16-132226:0
- 33,333,000 sharesCommon StockSEC:0001144204-16-132226:1
10 of 10 declarations